Share on StockTwits

PDI (NASDAQ:PDII) released its earnings data on Wednesday. The company reported ($0.11) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.14) by $0.03, Stock Ratings Network.com reports. The company had revenue of $32.80 million for the quarter, compared to the consensus estimate of $39.48 million.

A number of research firms have recently commented on PDII. Analysts at Zacks upgraded shares of PDI from an “underperform” rating to a “neutral” rating in a research note on Tuesday. They now have a $5.20 price target on the stock. Finally, analysts at Roth Capital cut their price target on shares of PDI from $10.00 to $9.00 in a research note on Tuesday, March 4th.

Shares of PDI (NASDAQ:PDII) traded down 5.92% during mid-day trading on Wednesday, hitting $4.77. 1,355 shares of the company’s stock traded hands. PDI has a 52-week low of $3.82 and a 52-week high of $6.25. The stock has a 50-day moving average of $4.75 and a 200-day moving average of $5.03. The company’s market cap is $73.3 million.

PDI, Inc provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.